MXC.L Share News (MXC)

IN BRIEF: MGC Pharmaceuticals raises GBP650,000 in subscription

MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in the production and development of plant-derived medicines - Conditionally raises GBP650,000, before expenses, through a placing and subscription of 541.7 million shares at a price of 0.12 pence per share. This represents a 57% discount from the closing price of 0.28p per share on Wednesday. The company also raises GBP50,000 from its Chief Executive Officer & Managing Director Roby Zomer in a convertible loan agreement.

IN BRIEF: MGC Pharma to receive USD150,000 downpayment for AMC order

MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in the production and development of plant-derived medicines - Clarifies that it will receive USD150,000 down payment on a USD1 million order for ArtemiC placed by AMC last week. Says further USD850,000 will be paid upon completion of production and dispatch of the order, expected for September.

MGC Pharmaceuticals shares up after USD1 million ArtemiC order

(Alliance News) - MGC Pharmaceuticals Ltd shares jumped on Friday morning after it announced a USD1 million order from AMC Pharma to produce ArtemiC, an over-the-counter version of CimetrA.

TRADING UPDATES: Mycelx wins deal; 88 Energy buys in Texas

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

TRADING UPDATES: Pendragon quarterly trading momentum maintained

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

UK shareholder meetings calendar - next 7 days

IN BRIEF: MGC Pharmaceuticals epilepsy treatment delivered in UK

MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in plant-inspired medicines - Says its investigational medicinal product, CannEpil, has been successfully delivered to its first UK patients through I Am Billy Foundation. Says CannEpil also has been delivered to its first patient in the UK through a named patient request programme.

IN BRIEF: MGC Pharmaceuticals rejigs board to reflect strategic change

MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in plant-inspired medicines - Says Brett Mitchell and Nativ Segev, will step down from the board, reflecting the changing direction of the company as it moves away from the medicinal cannabis sector toward a more pharma-focused business strategy. Stephen Parker, currently non-executive director, will replace Mitchell as interim non-executive chair. A new Australian non-executive director will also be appointed. Appoints Oberon Capital as joint broker in the UK with immediate effect alongside Peterhouse Capital.

IN BRIEF: MGC Pharmaceuticals completes GBP2.1 million fundraise

MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in plant-inspired medicines - Raises GBP2.1 million via a fundraising announced on Tuesday, which has now closed. Shares issued under the placing will be admitted to London Stock Exchange on April 18. In addition, MGC secures GBP256,590 in a separate offer to Australian and UK high-net-worth investors.

IN BRIEF: MGC Pharmaceuticals says CannEpil available in UK

MGC Pharmaceuticals Ltd - Perth, Australia-based pharmaceutical company specialising in plant-inspired medicines - Says its investigational medicinal product CannEpil for patients suffering from refractory epilepsy is now available in the UK by named patient request to be prescribed by doctors. The product is now in the process of a clinical development programme.

TRADING UPDATES: Lords Group buys Chiltern Timber; SRT wins contract

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday not separately reported by Alliance News:

MGC Pharma's Covid-19 drug ArtemiC available over-the-counter in US

(Alliance News) - MGC Pharmaceuticals Ltd on Tuesday said its ArtemiC product has now been listed as an over-the-counter, non-prescription drug in the US, while its supply and distribution partner AMC Holdings Inc has placed a USD2 million order.

TRADING UPDATES: SigmaRoc Sweden boost; Mosman's Cinnabar-1 success

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

TRADING UPDATES: Poolbeg patent boost; Resolute Mining resource up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and Tuesday not separately reported by Alliance News:

EARNINGS UPDATES: Kitwave hails rise in annual revenue and profit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: